Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying

Nathanael A. Stocke, Samantha A. Meenach, Susanne M. Arnold, Heidi - Mansour, J. Zach Hilt

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Targeted pulmonary delivery facilitates the direct application of bioactive materials to the lungs in a controlled manner and provides an exciting platform for targeting magnetic nanoparticles (MNPs) to the lungs. Iron oxide MNPs remotely heat in the presence of an alternating magnetic field (AMF) providing unique opportunities for therapeutic applications such as hyperthermia. In this study, spray drying was used to formulate magnetic nanocomposite microparticles (MnMs) consisting of iron oxide MNPs and d-mannitol. The physicochemical properties of these MnMs were evaluated and the in vitro aerosol dispersion performance of the dry powders was measured by the Next Generation Impactor®. For all powders, the mass median aerosol diameter (MMAD) was <5 μm and deposition patterns revealed that MnMs could deposit throughout the lungs. Heating studies with a custom AMF showed that MNPs retain excellent thermal properties after spray drying into composite dry powders, with specific absorption ratios (SAR) > 200 W/g, and in vitro studies on a human lung cell line indicated moderate cytotoxicity of these materials. These inhalable composites present a class of materials with many potential applications and pose a promising approach for thermal treatment of the lungs through targeted pulmonary administration of MNPs.

Original languageEnglish (US)
Pages (from-to)320-328
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume479
Issue number2
DOIs
StatePublished - Feb 20 2015
Externally publishedYes

Fingerprint

Nanocomposites
Nanoparticles
Lung
Aerosols
Powders
Hot Temperature
Mannitol
Magnetic Fields
Fever
Cell Line

Keywords

  • Dry powder inhalation aerosols
  • Iron oxide
  • Magnetic nanoparticles
  • Nanocomposites
  • Remote heating
  • Spray drying

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying. / Stocke, Nathanael A.; Meenach, Samantha A.; Arnold, Susanne M.; Mansour, Heidi -; Hilt, J. Zach.

In: International Journal of Pharmaceutics, Vol. 479, No. 2, 20.02.2015, p. 320-328.

Research output: Contribution to journalArticle

@article{1774b736288f4dfc9285d9d4dea91b7b,
title = "Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying",
abstract = "Targeted pulmonary delivery facilitates the direct application of bioactive materials to the lungs in a controlled manner and provides an exciting platform for targeting magnetic nanoparticles (MNPs) to the lungs. Iron oxide MNPs remotely heat in the presence of an alternating magnetic field (AMF) providing unique opportunities for therapeutic applications such as hyperthermia. In this study, spray drying was used to formulate magnetic nanocomposite microparticles (MnMs) consisting of iron oxide MNPs and d-mannitol. The physicochemical properties of these MnMs were evaluated and the in vitro aerosol dispersion performance of the dry powders was measured by the Next Generation Impactor{\circledR}. For all powders, the mass median aerosol diameter (MMAD) was <5 μm and deposition patterns revealed that MnMs could deposit throughout the lungs. Heating studies with a custom AMF showed that MNPs retain excellent thermal properties after spray drying into composite dry powders, with specific absorption ratios (SAR) > 200 W/g, and in vitro studies on a human lung cell line indicated moderate cytotoxicity of these materials. These inhalable composites present a class of materials with many potential applications and pose a promising approach for thermal treatment of the lungs through targeted pulmonary administration of MNPs.",
keywords = "Dry powder inhalation aerosols, Iron oxide, Magnetic nanoparticles, Nanocomposites, Remote heating, Spray drying",
author = "Stocke, {Nathanael A.} and Meenach, {Samantha A.} and Arnold, {Susanne M.} and Mansour, {Heidi -} and Hilt, {J. Zach}",
year = "2015",
month = "2",
day = "20",
doi = "10.1016/j.ijpharm.2014.12.050",
language = "English (US)",
volume = "479",
pages = "320--328",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying

AU - Stocke, Nathanael A.

AU - Meenach, Samantha A.

AU - Arnold, Susanne M.

AU - Mansour, Heidi -

AU - Hilt, J. Zach

PY - 2015/2/20

Y1 - 2015/2/20

N2 - Targeted pulmonary delivery facilitates the direct application of bioactive materials to the lungs in a controlled manner and provides an exciting platform for targeting magnetic nanoparticles (MNPs) to the lungs. Iron oxide MNPs remotely heat in the presence of an alternating magnetic field (AMF) providing unique opportunities for therapeutic applications such as hyperthermia. In this study, spray drying was used to formulate magnetic nanocomposite microparticles (MnMs) consisting of iron oxide MNPs and d-mannitol. The physicochemical properties of these MnMs were evaluated and the in vitro aerosol dispersion performance of the dry powders was measured by the Next Generation Impactor®. For all powders, the mass median aerosol diameter (MMAD) was <5 μm and deposition patterns revealed that MnMs could deposit throughout the lungs. Heating studies with a custom AMF showed that MNPs retain excellent thermal properties after spray drying into composite dry powders, with specific absorption ratios (SAR) > 200 W/g, and in vitro studies on a human lung cell line indicated moderate cytotoxicity of these materials. These inhalable composites present a class of materials with many potential applications and pose a promising approach for thermal treatment of the lungs through targeted pulmonary administration of MNPs.

AB - Targeted pulmonary delivery facilitates the direct application of bioactive materials to the lungs in a controlled manner and provides an exciting platform for targeting magnetic nanoparticles (MNPs) to the lungs. Iron oxide MNPs remotely heat in the presence of an alternating magnetic field (AMF) providing unique opportunities for therapeutic applications such as hyperthermia. In this study, spray drying was used to formulate magnetic nanocomposite microparticles (MnMs) consisting of iron oxide MNPs and d-mannitol. The physicochemical properties of these MnMs were evaluated and the in vitro aerosol dispersion performance of the dry powders was measured by the Next Generation Impactor®. For all powders, the mass median aerosol diameter (MMAD) was <5 μm and deposition patterns revealed that MnMs could deposit throughout the lungs. Heating studies with a custom AMF showed that MNPs retain excellent thermal properties after spray drying into composite dry powders, with specific absorption ratios (SAR) > 200 W/g, and in vitro studies on a human lung cell line indicated moderate cytotoxicity of these materials. These inhalable composites present a class of materials with many potential applications and pose a promising approach for thermal treatment of the lungs through targeted pulmonary administration of MNPs.

KW - Dry powder inhalation aerosols

KW - Iron oxide

KW - Magnetic nanoparticles

KW - Nanocomposites

KW - Remote heating

KW - Spray drying

UR - http://www.scopus.com/inward/record.url?scp=84920997238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920997238&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2014.12.050

DO - 10.1016/j.ijpharm.2014.12.050

M3 - Article

C2 - 25542988

AN - SCOPUS:84920997238

VL - 479

SP - 320

EP - 328

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 2

ER -